A common medication used to treat diabetes could nearly halve the risk of dementia, a new study suggests.
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are a class of prescription drugs that help lower blood sugar levels in adults with type 2 diabetes. They work by preventing the kidneys from reabsorbing sugar created by the body, causing the excess sugar to leave in the urine.